We have introduced antibiotics before, and its invention makes bacterial infections no longer a fear. However, there is a more terrifying microorganism-virus. Viruses are highly dependent on other living organisms […]
The birth of penicillin in 1943 opened the golden age of antimicrobial therapy. However, after the 1980s, large pharmaceutical companies faced major scientific challenges in finding new antibiotics to solve […]
The blood-brain barrier (BBB) refers to the barrier between blood plasma and brain cells formed by brain capillary walls and glial cells, and the barrier between plasma and cerebrospinal fluid […]
Lung Cancer 1.Tilelizumab’s second-line or third-line treatment of non-small cell lung cancer Phase III RATIONALE 303 trial reached its primary clinical endpoint. On November 17, BeiGene announced the interim analysis […]
Nearly 500 million people in the world suffer from diabetes, mainly type 2 diabetes, and this number is expected to soar in the next few years. Diabetes is also associated […]
A recent article published by the well-known medical and health information website Xconomy pointed out that many new drugs are expected to be approved to enter the market before the end of […]
For the deadliest animals on earth, venom is their deadly weapon. They use venom to defend themselves or attack predators. There are hundreds of animals in nature with hypodermic syringes that […]
Ono Pharmaceutical recently announced that its BTK inhibitor Velexbru (tirabrutinib hydrochloride, 80mg tablet) has been approved in Japan for the treatment of Fahrenheit macroglobulinemia (WM) and lymphocytic lymphoma (LPL). Velexbru is a highly […]
The latest research shows that the new small molecule compound Me6TREN can promote the regeneration of intestinal stem cells after radiation, and is expected to become a candidate drug for the […]
BioMarin is a global biotechnology company dedicated to developing and commercializing innovative therapies for patients with severe and life-threatening rare and ultra-rare genetic diseases. Its product portfolio includes seven commercial […]